Trypanosoma cruzi screening in Texas blood donors, 2008-2012

Epidemiology and Infection

Volumn 144, Issue 5, 2016, Pages 1010-1013

  Garcia, M N ^a   Woc Colburn, L ^a   Rossmann, S N ^b   Townsend, R L ^c   Stramer, S L ^c   Bravo, M ^d   Kamel, H ^d   Beddard, R ^e   Townsend, M ^f   Oldham, R ^f   Bottazzi, M E ^a   Hotez, P J ^a   Murray, K O ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c AMERICAN RED CROSS   (United States)

^d Blood Systems Incorporated   (United States)

^e South Texas Blood and Tissue Center   (United States)

^f Coffee Memorial Blood Center ^*  (United States)

Author keywords

Blood donors; Chagas disease; repeat reactive; RIPA; risk factors; seroprevalence; Trypanosoma cruzi

Indexed keywords

PROTOZOON ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD DONOR; CHAGAS DISEASE; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK POPULATION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; POVERTY; PREVALENCE; RADIOIMMUNOPRECIPITATION; RISK FACTOR; UNITED STATES; BLOOD; ISOLATION AND PURIFICATION; MASS SCREENING; MIDDLE AGED; PARASITOLOGY; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; TEXAS; TRYPANOSOMA CRUZI; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, PROTOZOAN; BLOOD DONORS; CHAGAS DISEASE; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS; TEXAS; TRYPANOSOMA CRUZI; YOUNG ADULT;

EID: 84971631162     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814002234     Document Type: Article

References (9)

1. Cantey PT, et al. The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion 2012; 52: 1922-1930.
2. Custer B, et al. Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi. Transfusion 2012; 52: 1901-1911.
3. American Association of Blood Banks. Chagas biovigi lance network (http://www.aabb.org/programs/biovigilance/Pages/chagas.aspx). Accessed 8 July 2014.
4. US Census Bureau. American fact finder (http://factfinder2.census.gov/faces/nav/jsf/pages/index.xhtml). Accessed 8 July 2014.
5. Lee BY, et al. Global economic burden of Chagas disease: a computational simulation model. Lancet Infectious Diseases 2013; 13: 342-348.
6. Sarkar S, et al. Chagas disease risk in Texas. PLoS Neglected Tropical Diseases 2010; 4: e836
7. Beard CB, et al. Chagas disease in a domestic transmission cycle in southern Texas, USA. Emerging Infectious Diseases 2003; 9: 103-105.
8. Bern C, et al. Trypanosoma cruzi and Chagas disease in the United States. Clinical Microbiology Reviews 2011; 24: 655-681.
9. Leiby DA, et al. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 2002; 42: 549-555.